Jeff Marion | July 9, 2020 | Dangerous Drugs, Unsafe Products

In September of 2019, the manufacturers of Ranitidine, the active ingredient in Zantac (an antacid), pulled their product from the shelves. Not only was the drug not available for prescription, but the over the counter version is no longer available as well.

Studies found that Ranitidine, when exposed to light or heat, produced a known carcinogen called NDMA. NDMA is found in rocket fuel and pesticides. Ranitidine converts to NDMA when it is exposed to light or heat. When a consumer ingests Ranitidine, NDMA is created as the stomach breaks down the pills. The amount of NDMA in a dose of Ranitidine or Zantac far exceeds the allowable limit imposed by the FDA.

There are any number of cancers that are associated with Ranitidine. These include:

-Breast Cancer

-Bladder Cancer

-Digestive Cancers (stomach, pancreatic, colorectal)

-Prostate Cancer in men under 65

-Non-Hogdkins Lymphoma

This list is not exhaustive. There is emerging science that there are any number of cancers that are caused by NDMA exposure. In fact, NDMA can pass through the placental wall. Many doctors recommend Zantac to pregnant women. Therefore, it is possible that many childhood cancers can be traced back to Zantac/Ranitidine use.

Cases have been filed recently in federal court in Florida. You may need to act fast to get your case filed. If you, or someone you know, has taken Zantac, Ranitidine, or any generic over the counter version, and has had a diagnosis of cancer, contact me immediately.